Zhou G - Search Results

1

CHAF1B promotes the progression of lung squamous-cell carcinoma by inhibiting SETD7 expression.

Zheng Z, Lin Y, Guo H, Liu Z, Jie X, Wang G, Zhou G. Zheng Z, et al. Among authors: zhou g. Front Med. 2025 Jan 25. doi: 10.1007/s11684-024-1122-2. Online ahead of print. Front Med. 2025. PMID: 39862337

2

Genomic variations in the counterpart normal controls of lung squamous cell carcinomas.

Zhang D, Qu L, Zhou B, Wang G, Zhou G. Zhang D, et al. Among authors: zhou g, zhou b. Front Med. 2018 Jun;12(3):280-288. doi: 10.1007/s11684-017-0580-1. Epub 2017 Nov 28. Front Med. 2018. PMID: 29185122

3

Innate immune checkpoint Siglec10 in cancers: mining of comprehensive omics data and validation in patient samples.

Zhang C, Zhang J, Liang F, Guo H, Gao S, Yang F, Guo H, Wang G, Wang W, Zhou G. Zhang C, et al. Among authors: zhou g. Front Med. 2022 Aug;16(4):596-609. doi: 10.1007/s11684-021-0868-z. Epub 2022 Jan 24. Front Med. 2022. PMID: 35075579

4

Mitochondrial-associated programmed-cell-death patterns for predicting the prognosis of non-small-cell lung cancer.

Shi X, Han S, Wang G, Zhou G. Shi X, et al. Among authors: zhou g. Front Med. 2024 Nov 22. doi: 10.1007/s11684-024-1093-3. Online ahead of print. Front Med. 2024. PMID: 39576480

5

Degradation of SARS-CoV-2 receptor ACE2 by the E3 ubiquitin ligase Skp2 in lung epithelial cells.

Wang G, Zhao Q, Zhang H, Liang F, Zhang C, Wang J, Chen Z, Wu R, Yu H, Sun B, Guo H, Feng R, Xu K, Zhou G. Wang G, et al. Among authors: zhou g. Front Med. 2021 Apr;15(2):252-263. doi: 10.1007/s11684-021-0837-6. Epub 2021 Jan 29. Front Med. 2021. PMID: 33511555 Free PMC article.

6

High frequency of alternative splicing variants of the oncogene Focal Adhesion Kinase in neuroendocrine tumors of the pancreas and breast.

Xie D, Wang Z, Sun B, Qu L, Zeng M, Feng L, Guo M, Wang G, Hao J, Zhou G. Xie D, et al. Among authors: zhou g. Front Med. 2023 Oct;17(5):907-923. doi: 10.1007/s11684-023-1009-7. Epub 2023 Sep 8. Front Med. 2023. PMID: 37682378

7

The E3 ubiquitin ligase TRAF6 controls CTLA-4 turnover and promotes T-cell-mediated antitumor immunity.

Jie XL, Guo H, Zhou GB. Jie XL, et al. Cell Mol Immunol. 2024 Jan;21(1):97-99. doi: 10.1038/s41423-023-01105-x. Epub 2023 Dec 11. Cell Mol Immunol. 2024. PMID: 38082145 Free PMC article. No abstract available.

8

Oncogenic functions and therapeutic potentials of targeted inhibition of SMARCAL1 in small cell lung cancer.

Sun BB, Wang GZ, Han SC, Yang FY, Guo H, Liu J, Liu YT, Zhou GB. Sun BB, et al. Cancer Lett. 2024 Jun 28;592:216929. doi: 10.1016/j.canlet.2024.216929. Epub 2024 Apr 30. Cancer Lett. 2024. PMID: 38697461

9

Centipeda minima and 6-O-angeloylplenolin enhance the efficacy of immune checkpoint inhibitors in non-small cell lung cancer.

Wang M, Guo H, Sun BB, Jie XL, Shi XY, Liu YQ, Shi XL, Ding LQ, Xue PH, Qiu F, Cao W, Wang GZ, Zhou GB. Wang M, et al. Phytomedicine. 2024 Sep;132:155825. doi: 10.1016/j.phymed.2024.155825. Epub 2024 Jun 13. Phytomedicine. 2024. PMID: 38968790

10

Systematic analysis of concentrations of 52 elements in tumor and counterpart normal tissues of patients with non-small cell lung cancer.

Cheng X, Zhou YC, Zhou B, Huang YC, Wang GZ, Zhou GB. Cheng X, et al. Cancer Med. 2019 Dec;8(18):7720-7727. doi: 10.1002/cam4.2629. Epub 2019 Oct 23. Cancer Med. 2019. PMID: 31643147 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,872 results

Search Page

Filters